Fredun Pharmaceuticals Limited manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America. The company offers allopathic formulations, inclu...
Fredun Pharmaceuticals reported revenue of 4.52 billion INR for fiscal year 2025, up 30.3% from fiscal year 2024, and net income of 197.39 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 1.60 billion INR, up 57.0% from a year before. Its market capitalization was 26.53 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
No profile data available.